SEC 13F Intelligence

Boston Family Office LLC / ABBV

Boston Family Office LLC’s Abbvie Inc Position

Does Boston Family Office LLC own Abbvie Inc (ABBV)? Yes71.2K shares worth $15M (+1.03% of its 13F portfolio) as of Q1 2026, down from 71.2K shares the prior filed quarter.

Position Value
$15M
Q1 2026
Shares
71.2K
% of Portfolio
+1.03%
Quarters Held
29
currently held

Position History ABBV

Reported value by quarter
Q1 ’19: $6MQ1 ’19Q2 ’19: $5MQ3 ’19: $6MQ4 ’19: $7MQ1 ’20: $6MQ1 ’20Q2 ’20: $7MQ3 ’20: $7MQ4 ’20: $10MQ1 ’21: $10MQ1 ’21Q2 ’21: $10MQ3 ’21: $10MQ4 ’21: $12MQ1 ’22: $15MQ1 ’22Q2 ’22: $13MQ3 ’22: $11MQ4 ’22: $14MQ1 ’23: $13MQ1 ’23Q2 ’23: $11MQ3 ’23: $12MQ4 ’23: $12MQ1 ’24: $14MQ1 ’24Q2 ’24: $13MQ3 ’24: $15MQ4 ’24: $13MQ1 ’25: $15MQ1 ’25Q2 ’25: $13MQ3 ’25: $17MQ4 ’25: $16MQ1 ’26: $15MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202671.2K$15M+1.03%
Q4 202571.2K$16M+1.03%
Q3 202575.1K$17M+1.11%
Q2 202572.0K$13M+0.89%
Q1 202572.6K$15M+1.08%
Q4 202473.5K$13M+0.90%
Q3 202474.8K$15M+1.00%
Q2 202474.9K$13M+0.93%
Q1 202477.3K$14M+1.01%
Q4 202379.3K$12M+0.92%
Q3 202380.5K$12M+0.98%
Q2 202380.6K$11M+0.83%
Q1 202383.0K$13M+1.06%
Q4 202284.2K$14M+1.13%
Q3 202284.3K$11M+1.01%
Q2 202287.9K$13M+1.12%
Q1 202289.6K$15M+1.03%
Q4 202186.3K$12M+0.76%
Q3 202188.4K$10M+0.69%
Q2 202187.9K$10M+0.71%
Q1 202190.0K$10M+0.73%
Q4 202090.4K$10M+0.75%
Q3 202084.3K$7M+0.67%
Q2 202073.1K$7M+0.70%
Q1 202073.5K$6M+0.66%
Q4 201973.6K$7M+0.62%
Q3 201973.3K$6M+0.58%
Q2 201973.8K$5M+0.56%
Q1 201975.0K$6M+0.65%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boston Family Office LLC’s full portfolio or all institutional holders of ABBV.